Subscribe to our newsletter

IBD News Today – Corrona Enrolls First Patient in Novel IBD Registry to Study Crohn’s Disease, Ulcerative Colitis

CorEvitas is now part of Thermo Fisher Scientific. Read More.

Corrona, a provider of U.S. disease registries, has enrolled the first patient in its novel inflammatory bowel disease (IBD) registry, launched in May 2017.

This is the first national registry to collect data from patients with ulcerative colitis, Crohn’s disease and other IBDs. Corrona joined the Crohn’s and Colitis Center at Brigham and Women’s Hospital of Harvard Medical School and Pfizer to provide expertise, tools and resources that fit with the drug discovery process.

Read more……